Medicalgrade polymer materials are an essential part of the modern healthcare system. These polymers find application in suture materials, tissue adhesives, and vascular grafts, materials for cosmetic implants, dental composites, contact and intraocular lenses. Medical polymers are used for drug delivery and used to solve bioseparation problems.
Market Dynamics
High prevalence of cardiovascular diseases is expected to propel growth of the medical polymer market. For instance, according to the American Heart Association's Heart and Stroke Statistics 2019 Update, around 48% of all adults in the U.S. suffered from some type of CVD in 2016. Moreover, approval and launch of implantable drug delivery devices is also expected to aid in growth of the medical polymer market. For instance, in February 2020, Innocoll Holdings Limited, a specialty pharmaceutical company, resubmitted the NDA to the U.S. FDA for XARACOLL (bupivacaine HCl collagen-matrix implants), an investigational drug-device for the management of postsurgical pain after open inguinal hernia surgery.
Launch of contact lenses is expected to propel growth of the medical polymer market. For instance, in May 2020 , CooperVision launched Biofinity toric multifocal contact lenses in the U.S.
Major players operating in the medical polymer market are focused on approval and launch of new products to expand their product portfolio. For instance, in October 2020, Kumovis GmbH announced to demonstrate over 10 medical-grade 3D-printing polymers at virtual Compamed and Formnext Connect online events in November 2020.
Competitive Analysis
Major players operating in the medical polymer market include, Bayer AG, Evonik Industries, Celanese, DuPont, Dow Chemical, Henkel, Kumovis GmbH, Nexa3D, Eastman Chemical, Huntsman, Lubrizol, Ensinger, Trinseo, BASF, Arkema, Biomerics, and DSM.
Major players operating in the medical polymer market are focused on approval and launch of new products to expand their product portfolio. For instance, in July 2020, Henkel, in collaboration with Nex3D, a maker of stereolithography-based 3D printers, launched a polypropylene-like material suited for 3D printing biocompatible medical and wearable devices. The commercially available xMED412 is entirely based on the Loctite MED412 material and is covered by all of its associated clearances, tests, and certifications, as per Henkel.
Similarly, in August 2020, Nexa3D, the maker of ultra-fast polymer production 3D printers, announced it plans to demonstrate its expanded portfolio of polymer production solutions that now include both photoplastic and thermoplastic capabilities at the virtual ASME AM Industry Summit on August 11 and 12.
In-depth report on Medical Polymer Market by Coherent Market Insights:
https://www.coherentmarketinsights.com/ongoing-insight/medical-polymer-market-4163
No comments:
Post a Comment